QuantumPharm, Inc. (2228) Stock Statistics & Valuation Metrics

QuantumPharm, Inc. has a market cap or net worth of HK$33.32B. The enterprise value is HK$24.98K.

QuantumPharm, Inc. has 4,301,475,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

QuantumPharm, Inc.’s return on equity (ROE) is 0.01 and return on invested capital (ROIC) is -4.98%.

The current PE Ratio of QuantumPharm, Inc. is ―. QuantumPharm, Inc.’s PEG ratio is -2.56.

In the last 12 months, QuantumPharm, Inc. had revenue of 781.85M and earned 120.54M in profits. Earnings per share was 0.03.

In the last 12 months, operating cash flow was -279.77M and capital expenditures -79.44M, giving a free cash flow of -359.21M billion.

QuantumPharm, Inc. pays an annual dividend of HK$0.007, resulting in a dividend yield of 3.17%

QuantumPharm, Inc. upcoming earnings date is Apr 1, 2027, Before Open (Confirmed).

QuantumPharm, Inc. as a current ratio of 14.77, with Debt / Equity ratio of 34.66%

In the past 12 months, QuantumPharm, Inc. has paid 758.84K in taxes.

QuantumPharm, Inc. EV to EBITDA ratio is 118.26, with an EV/FCF ratio of -149.98.

QuantumPharm, Inc. has HK$8.67B in cash and marketable securities with HK$3.12B in debt, giving a net cash position of HK$5.55B billion.

Gross margin is 51.52%, with operating margin of -63.50%, and net profit margin of 15.42%.

The average price target for QuantumPharm, Inc. is HK$9.20, which is 11.43% higher than the current price. The consensus rating is Moderate Buy